MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion-dependent thalassemia: An algorithm to guide clinical use when availability is limited

MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion-dependent thalassemia: An algorithm to guide clinical use when availability is limited

Saved in:

Bibliographic Details
Main Authors:	Vip Viprakasit, Amr Ajlan, Yesim Aydinok, Basim A.A. Al Ebadi, Hany Dewedar, Ahmed S. Ibrahim, Lamis Ragab, Omar Trad, Ahmed S. Wataify, Lily L.L. Wong, Ali T. Taher
Other Authors:	University of Babylon
Format:	Letter
Published:	2019
Subjects:	Medicine
Online Access:	https://repository.li.mahidol.ac.th/handle/123456789/46655
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Mahidol University

Similar Items

Treating iron overload in patients with non-transfusion-dependent thalassemia
by: Ali T. Taher, et al.
Published: (2018)

When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia
by: A. T. Taher, et al.
Published: (2018)

Current approach to iron chelation in children
by: Yesim Aydinok, et al.
Published: (2018)

Revisiting the non-transfusion-dependent (NTDT) vs. transfusion-dependent (TDT) thalassemia classification 10 years later
by: Khaled M. Musallam, et al.
Published: (2022)

Identification and key management of non-transfusion-dependent thalassaemia patients: Not a rare but potentially under-recognised condition
by: Vip Viprakasit, et al.
Published: (2018)

Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition
by: Vip Viprakasit, et al.
Published: (2017)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
by: Pandji Irani Fianza, et al.
Published: (2022)

Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study
by: Ali T. Taher, et al.
Published: (2018)

Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias
by: Wai Cheng Foong, et al.
Published: (2018)

Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias
by: Wai Cheng Foong, et al.
Published: (2018)

Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study
by: Ali T. Taher, et al.
Published: (2018)

Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo
by: Ali T. Taher, et al.
Published: (2018)

Geographical variations in current clinical practice on transfusions and iron chelation therapy across various transfusion-dependent anaemias
by: Vip Viprakasit, et al.
Published: (2018)

Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients
by: Natthaphat Siri-Angkul, et al.
Published: (2018)

Changing patterns in the epidemiology of β-thalassemia
by: Antonis Kattamis, et al.
Published: (2020)

Quality of life in patients with β-thalassemia: A prospective study of transfusion-dependent and non-transfusion-dependent patients in Greece, Italy, Lebanon, and Thailand
by: Maria Domenica Cappellini, et al.
Published: (2020)

Deferiprone for transfusional iron overload and its roles in developing countries
by: Vip Viprakasit, et al.
Published: (2018)

Deferiprone for transfusional iron overload and its roles in developing countries
by: Vip Viprakasit, et al.
Published: (2018)

Deferiprone for transfusional iron overload and its roles in developing countries
by: Vip Viprakasit, et al.
Published: (2018)

Adrenal insufficiency is prevalent in HbE/β-thalassaemia paediatric patients irrespective of their clinical severity and transfusion requirement
by: Pairunyar Nakavachara, et al.
Published: (2018)

Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies
by: Ali T. Taher, et al.
Published: (2022)

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload
by: Yesim Aydinok, et al.
Published: (2018)

Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study
by: Ali T. Taher, et al.
Published: (2019)

Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors
by: Adisak Tantiworawit, et al.
Published: (2018)

Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors
by: Tantiworawit A., et al.
Published: (2017)

Twice daily deferasirox significantly improves clinical efficacy in transfusion dependent thalassaemias who were inadequate responders to standard once daily dose
by: Bunchoo Pongtanakul, et al.
Published: (2018)

Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload
by: Dudley J. Pennell, et al.
Published: (2018)

A longitudinal study of growth and relation with anemia and iron overload in pediatric patients with transfusion-dependent thalassemia
by: Kwannapas Nokeaingtong, et al.
Published: (2018)

A longitudinal study of growth and relation with anemia and iron overload in pediatric patients with transfusion-dependent thalassemia
by: Nokeaingtong K., et al.
Published: (2017)

MRI imaging and histopathological study of brain iron overload of β-thalassemic mice
by: Paranee Yatmark, et al.
Published: (2020)

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
by: Gattermann,N., et al.
Published: (2015)

Bone mineral density in primarily preadolescent children with hemoglobin E/β-thalassemia with different severities and transfusion requirements
by: Pairunyar Nakavachara, et al.
Published: (2022)

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
by: Norbert Gattermann, et al.
Published: (2018)

Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemia
by: Ali T. Taher, et al.
Published: (2022)

Using of deferasirox and deferoxamine in refractory iron overload thalassemia
by: Chayamon Takpradit, et al.
Published: (2022)

A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload
by: Ellis J. Neufeld, et al.
Published: (2018)

An Automated Segmentation of R2∗ Iron-Overloaded Liver Images Using a Fuzzy C-Mean Clustering Scheme
by: Pairash Saiviroonporn, et al.
Published: (2019)

When available resources become negative resources: The effects of cognitive overload on memory sensitivity and criterion bias
by: Fox, J.R., et al.
Published: (2011)

Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia
by: Taher A.T.
Published: (2023)

Baseline levels of plasma endothelin-1 (ET-1) and changes during transfusion in thalassemic patients
by: Vip Viprakasit, et al.
Published: (2018)